P
LUNG
Pulmonx Corp
1.370
+0.010+0.74%After Hours: 1.389 +0.019 +1.39%16:44 04/10 EDT
OPEN/PREV CLOSE1.360/1.360
TODAY RANGE1.340-1.405
VOL193.55K
MARKET CAP57.86M
52 WEEK RANGE1.130-7.01
AVG VOL (3M)485.67K
% TURNOVER0.46%
TURNOVER--
P/E (TTM)-1.0322
% RANGE4.78%
EPS(TTM)-1.3273
P/E(FORWARD)-1.2178
P/B1.055
BVPS1.299
DIVIDEND--
P/S0.6309
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP51.34M
SHARES OUTSTANDING42.24M
NEXT EARNINGS04/28-05/04
FREE FLOAT37.47M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·6d ago
Pulmonx Insiders Forfeit On 14% Gains After Selling Stock
NASDAQ·03/06 20:19
Noteworthy Friday Option Activity: DAL, CVNA, LUNG
Benzinga·03/06 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·03/06 00:05
Pulmonx Earnings Call: Cost Discipline Amid Growth Pause
Dow Jones·03/05 20:37
Pulmonx Is Maintained at Buy by Canaccord Genuity
Dow Jones·03/05 20:37
Pulmonx Price Target Cut to $5.00/Share From $6.00 by Canaccord Genuity
Dow Jones·03/05 14:28
Pulmonx Is Maintained at Buy by D. Boral Capital
Dow Jones·03/05 14:28
Pulmonx Price Target Maintained With a $14.00/Share by D. Boral Capital
TipRanks·03/05 11:42
Pulmonx price target lowered to $5 from $6 at Canaccord
TipRanks·03/05 11:36
Pulmonx Secures New Term Loan and Issues Warrants
Seeking Alpha·03/04 23:22
Pulmonx outlines 2026 revenue target of $90M-$92M with cost realignment and renewed U.S. sales focus
NASDAQ·03/04 22:35
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
Same Industry
Name/Symbol
Change%
Price